title: First reported use of elvitegravir and cobicistat during pregnancy.
authors.affiliation: aDepartment of Pharmacy bDepartment of Pharmacology and Toxicology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands cInfectious Diseases Department, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Stein
authors.initials: S
authors.lastname: Schalkwijk
authors.forename: Angela
authors.initials: A
authors.lastname: Colbers
authors.forename: Deborah
authors.initials: D
authors.lastname: Konopnicki
authors.forename: Rick
authors.initials: R
authors.lastname: Greupink
authors.forename: Frans G M
authors.initials: FG
authors.lastname: Russel
authors.forename: David
authors.initials: D
authors.lastname: Burger
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000069547:Cobicistat / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010949:Plasma / Q000737:chemistry; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D015363:Quinolones / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D015363:Quinolones; C509700:elvitegravir; D000069547:Cobicistat